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ABSTRACT
The discovery and development of DNA-editing
nucleases (Zinc Finger Nucleases, TALENs,
CRISPR/Cas systems) has given scientists the
ability to precisely engineer or edit genomes as
never before. Several different platforms, proto-
cols and vectors for precision genome editing
are now available, leading to the development of
supporting web-based software. Here we present
the Gene Sculpt Suite (GSS), which comprises three
tools: (i) GTagHD, which automatically designs
and generates oligonucleotides for use with the
GeneWeld knock-in protocol; (ii) MEDJED, a ma-
chine learning method, which predicts the extent
to which a double-stranded DNA break site will
utilize the microhomology-mediated repair pathway;
and (iii) MENTHU, a tool for identifying genomic
locations likely to give rise to a single predomi-
nant microhomology-mediated end joining allele
(PreMA) repair outcome. All tools in the GSS are
freely available for download under the GPL v3.0
license and can be run locally on Windows, Mac
and Linux systems capable of running R and/or
Docker. The GSS is also freely available online at
www.genesculpt.org.
INTRODUCTION
Recent additions to the gene editing toolbox include meth-
ods for identification of off-target sites (1,2), strategies
for improving nuclease specificity (3) and the expansion
of nuclease targeting capabilities (4–7). Other approaches
have focused on DNA double-strand break (DSB) repair
by increasing the efficiency of homology-directed repair
(HDR)/homologous recombination (HR) or enhancing the
precision of the non-homologous end joining (NHEJ)DNA
repair pathway (8) (see Figure 1A and B). However, rel-
atively little work has been done to leverage homology-
mediated end joining (HMEJ) pathways (Figure 1C), in-
cludingmicrohomology-mediated end joining (MMEJ) and
single-strand annealing (SSA), and their potential to en-
hance the efficiency, precision and reproducibility of gene-
editing experiments.
Gene knock-in research has focused on increasing the
frequency of HDR/HR-based DSB repair to precisely in-
tegrate DNA cargo into a genomic locus, e.g. by modify-
ing the Cas9 protein (9) or inhibiting NHEJ (10). How-
ever, these methods can be difficult to implement and can be
highly inefficient, with only a few successful knock-ins per
hundreds of attempts. In addition, HR is almost completely
inhibited during the G1 phase of the cell cycle (11), which
inhibits targeted integration in post-mitotic cells and de-
creases gene-editing knock-in efficiencies in embryos.Much
of the recent research on enhancing gene knockouts has fo-
cused on NHEJ. This pathway has been thought to repair
DNA DSBs in an apparently random and inherently error-
prone fashion through the introduction of short indels. Re-
cent work has demonstrated that these errors are not neces-
sarily random and are frequently reproducible (12–14). Al-
though there are now methods for predicting repair profiles
(12,13), DSB sites that rely heavily on NHEJ––as opposed
toMMEJ––often lead to highlymosaic DSB repair profiles,
i.e., they do not display a single predominant repair out-
come (12).
In contrast, the Gene Sculpt Suite (GSS) tools (GTagHD
(15), MEDJED, and MENTHU (16)) leverage HMEJ, a
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Figure 1. DSB repair mechanisms. (A) NHEJ. The DNA DSB ends are bound by the Ku70–Ku80 heterodimer and undergo limited end-resection before
DNA polymerases and ligases repair the break. This process may perfectly repair the DSB break, but more frequently introduces short indels (red). (B)
HDR. When a DSB is detected, homologous sequences (blue and orange segments), frequently provided by a sister chromatid are used as a template to
repair the break (green). The resulting repair is usually precise. (C) HMEJ. HMEJ is a catch-all term for repair that utilizes short regions of homology,
including MMEJ and SSA. In both MMEJ and SSA, 5′-3′ end-resection exposes single-stranded DNA regions, where homologous sections (blue) anneal
with one another for repair. The overhanging DNA strands (red) are then clipped, resulting in a short deletion.MMEJ and SSA are mechanistically similar
but distinct pathways, utilizing different protein machinery. MMEJ also utilizes shorter regions of microhomology (∼2–25 bp) than SSA (>25 bp). SSA
end-resection can be extensive, so the pathway operates over larger nucleotide distances.
catch-all term for repair methods such as MMEJ and SSA,
which utilize short regions of sequence homology to repair
DSBs. GTagHD aids researchers in implementing the Ge-
neWeld protocol, which leverages HMEJ repair to intro-
duce targeted knock-ins with efficiencies much higher than
previously reported (15). MMEJ repairs frequently have
highly predictable outcomes based on the ‘strength’ of the
microhomology regions present (17). The relative strengths
of these homologies can be used to identify predominant
MMEJ allele (PreMA) reagents, i.e., nucleases that target
sites likely to result in a single MMEJ-based deletion com-
posing >50% of all repair outcomes (16). MENTHU and
MEDJED are GSS tools designed to assist researchers in
identifying PreMA reagents (16) and assessing the MMEJ
potential of potential target sites, respectively.
RESULTS
Availability and implementation
The GSS server is hosted on an Amazon Web Services
Elastic Compute Cloud Ubuntu 16.04 LTS instance. Each
tool was built in R (https://www.r-project.org/) using RStu-
dio (https://www.rstudio.com/) and is an RShiny (https:
//shiny.rstudio.com/) application contained in a Docker
(https://www.docker.com) image using the Open Analyt-
ics r-base image (https://hub.docker.com/r/openanalytics/r-
base). When a user visits a GSS tool URL, ShinyProxy
(https://www.shinyproxy.io) spins up a new container from
that tool’s Docker image; the user can then securely interact
within the confines of their container until they close their
browser page (Figure 2). ShinyProxy releases and deletes
the container one minute after the browser connection has
Figure 2. GSS Architecture. The GSS server uses ShinyProxy (https:
//www.shinyproxy.io/) to administer the Docker images (solid blue line)
for each GSS tool. When a user (blue circle) visits a GSS tool URL,
ShinyProxy creates a Docker container (dashed blue line), which essen-
tially is a temporary copy of theDocker image and allows a user to securely
interact within their own container. These containers are temporary, and
deleted once a user leaves their URL. A new container is spun up for each
unique user.
closed. This allows users to securely interact with the server
in their own virtual environments.
Each tool in the Suite is also available for down-
load via GitHub (https://github.com/Dobbs-Lab) and as
a Docker image through Docker Hub (https://hub.docker.
com/u/cmmann). These tools can be run locally on Win-
dows, Linux and Mac operating systems capable of run-
ning R v3.5.2 or later and/or Docker v18.06.1-ce or later.
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Figure 3. GeneWeld integration scheme (15). Short homologous sequences
from the integration site in the target genome (in blue and orange) are
cloned into the flanking regions of the donor plasmid cargo (green). When
the cargo is freed from the plasmid, the homologous regions promote the
efficient and precise integration of the cargo into the genomic locus using
HMEJ. The plasmid and genomic DNA DSBs are generated by two sepa-
rate gRNAs.
All tools are available at www.genesculpt.org, which also in-
cludes links to the GitHub and Docker Hub repositories.
GTagHD
GTagHD (pGTag Homology Designer) designs oligonu-
cleotides for use with the GeneWeld protocol ((15); see Fig-
ure 3). GeneWeld uses short sections of sequence homology
between a plasmid donor and a genomic locus to efficiently
and precisely integrate the plasmid cargo into the specified
locus, with minimal disruption to surrounding DNA. For
additional details regarding the GeneWeld technology and
its advantages over previous integration methods see Wier-
son et al. (15).
Input. GTagHD takes the genomic integration site with
surrounding DNA sequence and a user-specified length of
sequence homology between the plasmid donor and inte-
gration site as input. Users input the genomic locus as a
pastedDNA sequence orGenBank, RefSeq or Ensembl ID.
The gRNA sequence used to target the integration site is in-
put as the 20-nt guide (with no Protospacer AdjacentMotif
(PAM) sequence). GTagHD assumes a Cas9-like DSB will
be generated 3 bp upstream of the PAM sequence, allowing
flexibility in the choice of CRISPR nuclease in targeting the
genomic locus. We have developed two plasmid series for
use with the GeneWeld protocol, and although we strongly
recommend using these plasmids with GTagHD, the tool
also supports custom plasmids and cargos, which require
the gRNA sequence for freeing the cargo from the custom
plasmid as the only additional input.
Processing. GTagHD identifies the integration site using
the provided genomic gRNA sequence. GTagHD checks
to ensure that this gRNA appears exactly once within the
provided genomic DNA, but does not check for off-target
sites within the rest of the genome; several tools (including
CRISPRscan (18)) are available for this purpose. GTagHD
extracts the user-specified length of homologous sequence
surrounding the integration site, automatically adds addi-
tional nucleotides to repair frameshifts caused by the DSB,
adds restriction enzyme sites for cloning into the plasmid,
accounts for custom plasmid gRNAs (if provided) and per-
forms additional plasmid-series dependent processing.
Output. GTagHD outputs four oligonucleotide se-
quences: 5′ ‘forward’, 5′ ‘reverse’, 3′ ‘forward’ and 3′
‘reverse’. The oligonucleotides sequences can be down-
loaded as a text file and are ready-to-order. The synthetic
oligonucleotides can be easily cloned into a plasmid vector.
If a user chooses to use a plasmid from theGeneWeld series,
they can also download automatically-generated plasmid
maps containing their incorporated oligonucleotides in A
Plasmid Editor (ApE) format, which is compatible with the
GenBank format (gb).
Comparison to other methods. The GeneWeld protocol
was inspired by the PITCh protocol (19–20), which is
also available for designing knock-in construct guides
(http://www.mls.sci.hiroshima-u.ac.jp/smg/PITChdesigner/
index.html). However, GTagHD has a few features that
may make it more convenient for users than the PITCh
designer 2.0 webtool (21).
First, users can submit GenBank, RefSeq and Ensembl
IDs to specify their genomic locus, instead of copying
and pasting whole sequences as in PITCh 2.0. When us-
ing an ID, GTagHD can automatically identify and repair
frameshifts created by the DSB site to maintain the correct
codon and keep the original sequence in frame and intact.
PITCh 2.0 requires users to manually specify the reading
frame and corrects frameshifts by inserting ‘Cs’ or by delet-
ing a codon entirely, thus altering the original genomic se-
quence.
Second, GTagHD identifies the DSB integration site in
the genomic sequence from user-provided gRNA, and does
not require users to manually scroll through the sequence to
identify the location, as in PITCh 2.0.
Finally,GTagHDdoes not require any information about
the plasmid vector beyond (possibly) the gRNA sequence
used to free the cargo, whereas PITCh 2.0 requires sequence
context from the insert.
MEDJED
MEDJED (Microhomology Evoked Deletion Judication
EluciDation) is a random forest machine learning-based
method for predicting the extent to which a DSB site will
undergo MMEJ repair. MEDJED was trained on 66 and
tested on 23CRISPRCas9 sites inHeLa cells acquired from
Bae et al. (17). As shown in Figure 4, when comparing the
predicted proportion of MMEJ-based deletions against the
observed proportion of MMEJ-based deletions on an in-
dependent test set, MEDJED achieved a correlation coeffi-
cient of 85.2%, mean absolute error (MAE) of 10.3%, and
root mean square error (RMSE) of 12.0%.
Input. MEDJED takes a pasted DNA sequence between
20 and 200 nt in length as input and assumes theDSBoccurs
in the exact middle of the sequence.
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Figure 4. MEDJED performance. On a test set of 23 HeLa cell targets from (17), MEDJED achieves a Pearson Correlation Coefficient (PCC) of 85.2%,
MAEof 10.3% andRootMean Square Error (RMSE) of 12.0%. TheMEDJED-predictedMMEJ repair proportion (x-axis) is graphed against the observed
MMEJ repair proportion (y-axis).
Processing. MEDJED assesses the strengths of all
microhomologies present, utilizing features including
the minimum deleted sequence length, the maximum,
mean and standard deviation of the microhomology arm
lengths, and the maximum and standard deviation of
the Microhomology–Predictor pattern score (17). These
features are input into the MEDJED regression model.
Output. MEDJED returns a prediction of the proportion
of deletion repair outcomes at the provided site expected to
result from MMEJ-based repair. It also outputs the values
of the six features used in predicting the MMEJ-based re-
pair proportion, as well as a table of all the MMEJ-based
deletion outcomes for the targeted site. These outputs can
be downloaded individually or collectively as a zip file.
Comparison to other methods. The Microhomology–
Predictor (http://www.rgenome.net/mich-calculator/, (17)),
onwhichMEDJED is partially based, calculates an ‘out-of-
frame’ score for choosing DSB sites likely to generate out-
of-frame deletions; if the score is above 66, the site is recom-
mended for generating gene knockouts. Microhomology–
Predictor does not, however, predict the extent of MMEJ
at a particular site, and while the out-of-frame score tends
to correlate closely with the observed proportion of out-of-
frame repairs, it is not a probability of such events occur-
ring.
inDelphi (https://indelphi.giffordlab.mit.edu/, (13)) and
FORECasT (Favoured Outcomes of Repair Events at
Cas9 Targets, https://partslab.sanger.ac.uk/FORECasT,
(12)) both predict expected ‘repair profiles’ at a DSB
site––that is, they enumerate all possible repair outcomes
for a particular site (within a limited sequence window),
and compute the probability of each outcome. inDelphi
is notably feature-rich and offers the option to predict
probabilities in different cell types; however, determining
the probability of MMEJ-based repair for a particular
site requires additional calculations on the part of the
user. FORECasT, while simple to use, does not output an
intuitive human-readable result, requiring users to perform
remapping of each outcome to calculate the predicted
proportion of MMEJ repair.
MENTHU
MENTHU (Microhomology-mediated End joining
kNockout Target Heuristic Utility) identifies sites likely to
have a predominant microhomology-mediated end joining
allele (PreMA) repair outcome (16). MENTHU expands
on the Microhomology–Predictor tool algorithm (17),
which produces a ‘pattern score’ for each possible MMEJ-
based deletion within a sequence. This score is based on the
length, GC content and deleted sequence length expected
to be produced by the microhomology, with a higher score
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corresponding to a ‘stronger’ microhomology. MENTHU
evaluates the ratio between the two highest scoring dele-
tions as a surrogate for relative competitiveness between
microhomology sites in recruiting the MMEJ machinery,
in order to identify ‘low competition’ sites where a single
microhomology pairing is likely to be predominant. For
additional details, see Ata et al. (16).
Input. MENTHU takes a user-specified CRISPR or
TALEN nuclease and a target DNA region as input. Users
can choose from a list of CRISPR nucleases or can specify
custom nucleases by providing a PAM sequence, distance
betweenDSB site and PAM, and length of 5′ overhangs (for
nucleases producing sticky-end DSBs, like Cas12a). The ge-
nomic DNA target can be specified by pasting a DNA se-
quence or a GenBank, RefSeq or Ensembl ID. MENTHU
also allows users to specify exons to increase search speed
and biological relevance of the results.
Processing. MENTHU scans the input DNA for selected
nuclease target sites. For each matching site, MENTHU
identifies all microhomology pairings within an 80 bp win-
dow centered at the DSB site and then scores them ac-
cording to the algorithm employed by Microhomology–
Predictor (17). MENTHU then identifies sites in which the
highest scoring predicted deletion has ≤5 intervening nu-
cleotides between the microhomology arms in the wild type
sequence and calculates the quotient between its pattern
score and the next highest scoring microhomology. This ra-
tio is the MENTHU score.
Output. MENTHU outputs a table of likely PreMA
reagents in descending order of MENTHU score (Figure
5). The table consists of ten columns. The ‘Target Sequence’
provides the gRNA or TALEN sequence needed to induce
a DSB at a particular site. The ‘MENTHU Score’ column
contains the computedMENTHU score. The ‘Frame Shift’
column indicates whether the PreMA deletion generates a
frameshift. The ‘Tool Type’ provides the PAM sequence, in
the case of CRISPR nucleases, and the length of the arms
and spacer in the case of TALEN inputs. The ‘Strand’ col-
umn indicates whether the Target Sequence matches the
forward or complement strand. The ‘Exon ID’ gives the
exon in which the Target Sequence site occurs, while the
‘DSB Location’ gives the position of the nucleotide directly
to the left of the DSB site. The ‘Microhomology’ column
gives the sequence of the microhomology producing the
deletion. The ‘PreMA Sequence’ column shows the top pre-
dicted MMEJ deletion sequence (PreMA) for the site. The
‘Context’ column (not shown) gives the ‘wildtype’ sequence
corresponding to the PreMA region. The table is search-
able, sortable, and can be downloaded in CSV format. Tar-
gets can be filtered to show only recommended sites (with
MENTHU score > 1.5). By default, all sites for which the
top MMEJ deletion has ≤5 bp between microhomology
arms in wild type sequence are shown, although the results
can be filtered to show only recommended sites (MENTHU
score ≥ 1.5). Targets can also be filtered to display only T7-
compatible gRNAs.
Comparison to other methods. The Microhomology–
Predictor tool (17), FORECasT (12) and inDelphi (13)
all assist users in choosing sites for gene knockout. How-
ever, MENTHU has several key features that may make
it more convenient for some users. MENTHU utilizes
the Pattern Score devised by Bae et al. and used in the
Microhomology–Predictor tool (17). As previously de-
scribed, the Microhomology–Predictor uses the Pattern
Score to identify sites likely to produce a frameshift (and by
extension, gene knockout). In contrast, MENTHUuses the
ratio between Pattern Scores for variousMMEJ-based dele-
tion patterns to approximate ‘competition’ between avail-
able microhomologies for use by the MMEJ repair machin-
ery (16). This ‘competition score’ is then used to reduce mo-
saicism in repair outcomes.Microhomology–Predictor does
not offer any insights into the level of mosaicism in repair
outcomes. In addition, users can scan for only Cas9 NGG
sites, whereas MENTHU has been validated using TAL-
ENs and offers the ability to search for a wide variety of
PAMs.
MENTHU provides several conveniences over FORE-
CasT. The web interface for FORECasT does not allow
for automatic analysis of multiple DSB sites along a se-
quence. It also only supports NGG PAMs; if a non-NGG
PAM is of interest, it must be manually specified by its
numeric location in the sequence. In contrast, MENTHU
scans an input sequence for any targets matching one or
more user-specified PAMs or TALENs automatically. In
addition, while the FORECasT web interface outputs the
predicted repair outcome probabilities for the single speci-
fied target site, the downloadable output of the tool consists
of a machine-readable file containing a code specifying the
deletion, rather than the actual sequence. Thus, while the
ability of FORECasT to predict the sequence outcomes for
a given DSB is useful, the current web tool is of limited util-
ity for users who wish to locate those sites.
In contrast, inDelphi’s web interface is very feature-rich
and accepts any Cas9-like PAM. The ‘single’ mode allows
users to manually scan for PAM sites in five different cell
lines and then outputs the likely mutation probability pro-
file for each. inDelphi outputs additional information in-
cluding the predicted frameshift probabilities, the predicted
distribution of 1 bp insertions and of deletions up to 60 bp in
length, the ‘precision’ (the expected proportion of the most
prevalent mutation outcome for a given DSB), a ‘microho-
mology strength’ score, and the frameshift frequency, in ad-
dition to detailed information regarding the predicted out-
comes.
inDelphi can also be run in batch mode, allowing users
to access all of the features in ‘single’ mode for every poten-
tial DSB site along an input sequence. Additionally, users
can ask inDelphi to recommend gRNAs likely to produce
a specified genotypic outcome, which MENTHU does not
currently perform. However, this mode is limited to Cas9-
like outcomes and pasted input DNA sequences only. in-
Delphi’s ‘gene’ mode offers the ‘batch’ mode treatment for
precomputed human (hg38) and mouse (mm10) genes for
SpCas9 only. In contrast, MENTHU has been validated
in zebrafish models, and can perform expanded scanning
within a gene or genomic region of interest based on acces-
sion ID, allowing for greater flexibility in target site scan-
ning.
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Figure 5. Example MENTHU output table. Each row corresponds to a single DSB event. The ‘Target Sequence’ column contains the gRNA or TALEN
sequence required to generate the DSB. The ‘MENTHU Score’ column gives the ratio between the Microhomology–Predictor pattern scores of the top
two scoring microhomologies at the site; a DSB site is likely to produce a PreMA if the MENTHU Score is ≥1.5 (16). ‘The Frame Shift’ column indicates
whether the most frequent expected deletion pattern induces a frameshift. The ‘Tool Type’ gives the PAM sequence for CRISPR nucleases, and the left
arm length/spacer/right arm length combination for TALENs. The ‘Strand’ column indicates whether the ‘Target Sequence’ occurs on the forward or
complement strand. The ‘Exon ID’ provides the number of the exon in which the DSB site occurs; if no exon information is available, this value is 1.
The ‘DSB Location’ provides the index of the nucleotide to the left of the DSB site within the entire nucleotide sequence. The ‘Microhomology’ column
contains the sequence of the microhomology arms used to generate the deletion. The ‘PreMA Sequence’ gives the sequence of the predicted predominant
repair outcome. The ‘Context’ column (not shown) gives the sequence window used for MENTHU score calculations.
Unlike FORECasT and inDelphi, MENTHU has been
validated for TALEN platforms and supports scanning for
PreMA TALEN sites. Additionally, while none of these
tools (including MENTHU) have been validated for en-
zymes that generate staggered-DSBs, such as Cas12a/Cpf1,
MENTHU can provide predictions for these sites based
on our current understanding of MMEJ repair machinery
(Figure 6).
Ultimately, the intended functionality of MENTHU is
different from that of inDelphi and FORECasT, which are
designed to predict full mutational profiles resulting from
specific DSBs. In contrast, MENTHU aims to identify tar-
get sites that are likely to result in a particular outcome.
Genome engineers will find a more detailed description of
editing outcomes in inDelphi and FORECasT, but more
accessible targeting recommendations in MENTHU for a
wider variety of nucleases and input DNA sequences.
DISCUSSION
The tools in the GSS are designed to empower researchers
to deploy MMEJ-based gene editing, which allows them
to focus their efforts on the editing repair outcomes for
functional genomics and gene therapy applications. They
also enable users to accurately designHMEJ-based targeted
gene integration vectors by helping them design oligonu-
cleotides to implement the highly efficient GeneWeld strat-
egy for creating knock-in mutations, which has been re-
ported to yield ∼50% germline transmission rates (15).
All tools in the GSS are under active development. Ad-
ditional GeneWeld plasmid series are nearing completion
Figure 6. Strategy for handling staggered-cutting nucleases. End-resection
operates in a 5′-3′ fashion. 5′ overhangs produced by a staggered-cutting
nuclease will be removed during the resection phase. The eliminated se-
quence in the overhangs is thus unavailable for utilization in MMEJ. We
can approximate themicrohomologies available for use inMMEJ repair by
creating a pseudostring DNA sequence made up of the 5′ strand up until
the DSB site (orange) concatenated to the 3′ strand (blue). The 5′ over-
hangs (dashed lines) are effectively removed. This allows staggered DSBs
to be treated identically to blunt DSBs, after the 5′ overhangs are removed
from the sequence. The ‘Context’ column within the MENTHU results
table (see Figure 5) contains this pseudostring when a staggered-cutting
nuclease is chosen.
(J.M.Welker and J.J. Essner, personal communication), and
we will add tools for these to GTagHD as they are devel-
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oped. Work to further improve MENTHU performance in
targeting intronic sequences and to validateMENTHUper-
formance for editing with Cas12a systems is underway. We
are also using MENTHU to investigate the frequency and
occurrence of PreMA alleles (16) in various genomes and
producing genome browser tracks to display pre-computed
PreMA sites for the entire human genome.
DATA AVAILABILITY
The GSS is freely available online through www.genesculpt.
org.
Each tool is also freely available for download un-
der a GPL v3.0 license at their respective GitHub
pages (https://github.com/Dobbs-Lab/GTagHD,
https://github.com/Dobbs-Lab/MEDJED, and
https://github.com/Dobbs-Lab/MENTHU), which
have detailed installation instructions. Each tool
can also be downloaded as a Docker image from
https://hub.docker.com/r/cmmann/. The GSS was built
using a number of third-party R packages: shiny (https://
shiny.rstudio.com), shinyjs (https://deanattali.com/shinyjs),
stringr (https://cran.r-project.org/web/packages/stringr),
stringi (https://cran.r-project.org/web/packages/stringi),
plyr (https://cran.r-project.org/web/packages/plyr, (22)),
rentrez (https://cran.r-project.org/web/packages/rentrez,
(23)), rlist (https://cran.r-project.org/web/packages/rlist),
curl (https://cran.r-project.org/web/packages/curl),
randomForest (https://cran.r-project.org/web/
packages/randomForest, (24)), ggplot2 (https:
//ggplot2.tidyverse.org, (25)), rhandsontable (https:
//cran.r-project.org/web/packages/rhandsontable),
Biostrings (https://bioconductor.org/packages/release/bioc/
html/Biostrings.html), DT (https://rstudio.github.io/DT),
jsonlite (https://rdrr.io/cran/jsonlite, (26)), httr
(https://cran.r-project.org/web/packages/httr) and Bio-
conductor (https://bioconductor.org, (27)). All of these
packages are freely available, and code to quickly install
them is included in GSS installation instructions on
GitHub.
Plasmid maps for GeneWeld plasmids are available
throughGTagHD’sweb page.GeneWeld plasmids are avail-
able at AddGene: https://www.addgene.org/Jeffrey Essner/.
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